drugset / Trial / NCT01673191

A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

NCT01673191

Phase 2 Completed 40 enrolled Retinal Consultants of Arizona Allergan · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

There is a need to find an effective therapy for diabetic patients who develop macular edema after cataract surgery.

Timeline

Start
2012-11
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.7 mg Intravitreal
Comparator Ketorolac Other / unclassified Topical
Comparator Prednisolone Other / unclassified Topical